Rheumatoid Arthritis Pharmaceutical and Healthcare Analysis Information

Pune, India, 14th March 2018: WiseGuyReports announced addition of new report, titled “Rheumatoid Arthritis (RA) - Dynamic Market Forecast to 2025”.

Pune , India - March 14, 2018 /MarketersMedia/ —

Rheumatoid Arthritis (RA) is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the RA space, including regulatory, commercial, and clinical events as well as understand how all of these events will impact the projected market forecast.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3054186-rheumatoid-arthritis-ra-dynamic-market-forecast-to-2025

Key events covered in the Dynamic Market Forecast include -
- Regulatory filings
- Approval decisions
- Pricing changes
- Patent litigation
- Clinical trial data announcements
- Clinical trial failures
- Clinical trial timeline updates

Components of the slide deck include -
- Timeline of market-impacting events
- Key clinical trial landscape updates
- Detailed analysis of the most impactful events, including new primary research to gain Key Opinion Leader perspective
- Overview of updates to the forecast model based on anticipated future impact of events
- Forward-looking events calendar listing expected key updates to the RA competitive space through June 2018

Reasons to buy
- Recent Regulatory Events
- Recent Commercial Events
- Recent Clinical Events
- Market Dynamics Shifts Towards Biosimilars in the RA Setting
- Discontinuation of J&J’s Sirukumab for RA Creates Opportunity for Other IL-6 Inhibitors
- Increased Competition Among the Oral JAK Inhibitors in the RA Setting

Table of Content: Key Points
1. Dynamic Market Forecast Overview 5
1.1 Related Reports 6
1.2 Upcoming Related Reports 7
2. Executive Summary 8
2.1 Key Updates to RA Market Dynamics 9
2.1 Key Events in Update 10-12
2.2 Clinical Trial Landscape Updates 13
2.3 Pipeline Landscape Updates 14
2.4 Market Insight on Key Events 15
3. Event 1: Market Dynamics Shift Towards Biosimilars 16
3.1 Key Updates to Biosimilar Market Dynamics 17
3.2 Enbrel Biosimilars 18
3.3 Humira Biosimilars 19
3.4 Remicade Biosimilars 20
3.5 Rituxan Biosimilars 21
3.6 What Do Physicians Think? 22
3.7 Summary/Trends 23
3.8 Sources 24
4. Event 2: Discontinuation of Sirukumab Creates Opportunity for Other IL-6 Inhibitors 25
4.1 Key Updates to the Anti-IL-6 Market Dynamics 26
4.2 J&J, sirukumab 27
4.3 Regeneron/Sanofi, Kevzara (sarilumab) 28
4.4 What Do Physicians Think? 29
4.5 Summary/Trends 30
4.6 Sources 31
5. Event 3: Competition Among the Oral JAK Inhibitors 32
5.1 Key Updates to the JAK Inhibitor Market Dynamics 33
5.2 Eli Lilly, Olumiant (baricitinib) 34-35
5.3 AbbVie, upadacitinib 36
5.4 What Do Physicians Think? 37
5.5 Summary/Trends 38
5.6 Sources 39
6. Events Calendar 40
6.1 Key Events Expected to Occur H1 2018 41

ACCESS REPORT @ https://www.wiseguyreports.com/reports/3054186-rheumatoid-arthritis-ra-dynamic-market-forecast-to-2025

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Address: Office No. 528, Amanora Chambers
Phone: +1-646-845-9349

Source URL: https://marketersmedia.com/rheumatoid-arthritis-pharmaceutical-and-healthcare-analysis-information/314312

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 314312

More News From In The Headline

Tempest over Trump-Putin call turns into uproar over leaks

Mar 21, 2018

WASHINGTON — The tempest over President Donald Trump's congratulatory phone call to Vladimir Putin quickly grew on Wednesday into an uproar over White House leaks, sparking an internal investigation and speculation over who might be the next person Trump forces out of the West Wing. The White House, which has suffered frequent leaks — at times of notable severity — said in a statement it would be a "fireable offense and likely illegal" to leak Trump's briefing papers to the press, after word emerged that the president had been warned in briefing materials not to congratulate the Russian president on...

Facebook's Zuckerberg admits mistakes _ but no apology

Mar 21, 2018

NEW YORK — Breaking five days of silence, Facebook CEO Mark Zuckerberg admitted mistakes and outlined steps to protect user data in light of a privacy scandal involving a Trump-connected data-mining firm. Zuckerberg said Wednesday that Facebook has a "responsibility" to protect its users' data and if it fails, "we don't deserve to serve you." But Zuckerberg stopped short of apologizing. And he wrote "what happened" instead of "what we did," leaving Facebook one step removed from responsibility. Richard Levick, chairman of the crisis-management firm Levick, gave Zuckerberg's response a "B-" grade, in part because of how late it came....

AP FACT CHECK: Trump mangles Clinton comments on election

Mar 21, 2018

WASHINGTON — President Donald Trump is revisiting old battles — the political one against Hillary Clinton and real ones against the Islamic State — without a full command of the facts. On Iraq and Syria, Trump gave credit to himself for military progress that was made by Russia, the Syrian government, Iraqi forces, Iranian forces — and the U.S., under Trump and his predecessor, Barack Obama. On Clinton, he botched her recent comments about the 2016 election, wrongly stating that she thought women felt they needed approval from their husbands to vote for him. Her assertion was closer to the...

Fed raises key rate and foresees 2 more hikes this year

Mar 21, 2018

WASHINGTON — The Federal Reserve raised its key interest rate Wednesday in a vote of confidence in the U.S. economy's durability while signaling that it plans to continue a gradual approach to rate hikes for 2018 under its new chairman, Jerome Powell. The Fed said it expects to raise rates twice more this year. And it increased its estimate for rate hikes in 2019 from two to three, reflecting more optimistic expectations for growth and low unemployment. In a statement after its latest policy meeting, the Fed said it boosted its key short-term rate by a modest quarter-point to a...

Elon Musk's Tesla pay package could net him $50 billion

Mar 21, 2018

DETROIT — Shareholders of electric car and solar panel maker Tesla Inc. have approved an ambitious pay package for iconic CEO Elon Musk that could net him more than $50 billion if he meets lofty milestones over the next decade. A company filing Wednesday with the Securities and Exchange Commission showed shareholders supported the pay deal by a large margin. Tesla says the all-or-nothing package is worth $2.6 billion at current stock values, but that would rise dramatically if Musk meets 12 incremental goals including raising the company's market capitalization tenfold to $650 billion. Also included are targets to increase...

Sign up now!

About Us

In The Headline sought to bring professionalism back into journalism, bringing you only the most exclusive and the most impactive news from all over the globe.

Contact us: sales[at]intheheadline.com